Fluzone High-Dose Quadrivalent Northern Hemisphere - INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL Injection 0.7 mL

Reference details for licensed healthcare facility review and verification.

Fluzone High-Dose Quadrivalent Northern Hemisphere NDC Family 49281-0226 Fluzone High-Dose Quadrivalent Northern Hemisphere 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL

NDC 11	49281-0226-65
Product NDC	49281-0226
Generic Drug Name	INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
Brand Name	Fluzone High-Dose Quadrivalent Northern Hemisphere
Manufacturer	Sanofi Pasteur Inc.
Strength	60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL
Dosage Form	Injection
Drug Type	Intramuscular
Package Quantity	10 Syringe, Glass
Package Description	10 SYRINGE, GLASS in 1 PACKAGE (49281-226-65) / .7 mL in 1 SYRINGE, GLASS (49281-226-88)
Active Ingredients	Influenza A Virus A/Croatia/10136Rv/2023 X-425A (H3N2) Antigen (Formaldehyde Inactivated); Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1N1) Antigen (Formaldehyde Inactivated); Influenza B Virus B/Michigan/01/2021 Antigen (Formaldehyde Inactivated); Influenza B Virus B/Phuket/3073/2013 Antigen (Formaldehyde Inactivated)
Marketing Category	BLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL Injection is tracked under NDC 49281-0226-65 and rolls up into product family 49281-0226. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 10 Syringe, Glass.
Manufacturer: Sanofi Pasteur Inc..
Dosage form: Injection.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Fluzone High-Dose Quadrivalent Northern Hemisphere - INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL Injection 0.7 mL, NDC 49281-0226-65, is a Sanofi Pasteur Inc. 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL injection presentation packaged as 10 Syringe, Glass.

NDC search formats

Canonical NDC 11: 49281-0226-65
Digits-only NDC 11: 49281022665
Possible 10-digit display format: 49281-226-65 (4928122665)

Helpful product links

Search by brand name: Fluzone High-Dose Quadrivalent Northern Hemisphere
NDC 11: 49281-0226-65
Product family NDC: 49281-0226